ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Synthetic biology ‘control circuits’ could regulate cells like a thermostat – Genetic Literacy Project

Continue reading

2018-04-05 Michael Zand NEWS

Ribosome distribution key to programming cells – Lab News


Genetic Literacy Project

Synthetic biology ‘control circuits’ could regulate cells like a thermostat
Genetic Literacy Project
Synthetic biology offers a vision for the future of medicine, where cells could be re-engineered to fight diseases such as cancer and diabetes. For this to happen, scientists use viruses to infect and transfer new properties to cells so they behave in …

Continue reading

2018-04-05 Michael Zand NEWS

BI strikes billion-dollar cancer immunotherapy deal with OSE – pharmaphorum

pharmaphorumBI strikes billion-dollar cancer immunotherapy deal with OSEpharmaphorumBoehringer Ingelheim (BI) has struck a potential billion-dollar deal with OSE Immunotherapeutics to develop a new checkpoint inhibitor cancer immunotherapy, offering th… Continue reading

2018-04-05 Michael Zand NEWS

American CryoStem Enters Into Agreement to License its Patented Adipose Tissue and Stem Cell Technologies in … – GlobeNewswire (press release)


Lab News

Ribosome distribution key to programming cells
Lab News
Declan Bates, Professor of Bioengineering at the University of Warwick’s School of Engineering and Co-Director, Warwick Integrative Synthetic Biology Centre (WISB) said: “Synthetic Biology is about making cells easier to engineer so that we can address …

Continue reading

2018-04-05 Michael Zand NEWS

Lilly to develop encapsulated diabetes cell therapies through Sigilon deal – In-PharmaTechnologist.com

American CryoStem Enters Into Agreement to License its Patented Adipose Tissue and Stem Cell Technologies in …
GlobeNewswire (press release)
American CryoStem has licensed to Cryoviva (Thailand) Ltd., established in 2007, the rights to utilize the Company’s Standard Operating Procedures (SOP’s) to create and market the Company’s ATGRAFT™ tissue storage service and ATCELL™ adipose derived …

and more »

Continue reading

2018-04-05 Michael Zand NEWS

Synthetic biology club offers solutions to real world problems – Rocky Mountain Outlook

Rocky Mountain OutlookSynthetic biology club offers solutions to real world problemsRocky Mountain OutlookThe synthetic biology club members show off some of the tools they use to perform genetic science at Our Lady of the Snows in Canmore on Friday (… Continue reading

2018-04-05 Michael Zand NEWS

Gene Therapy Advances: What Health Execs Should Know – ModernMedicine


In-PharmaTechnologist.com

Lilly to develop encapsulated diabetes cell therapies through Sigilon deal
In-PharmaTechnologist.com
Eli Lilly has licensed Sigilon Therapeutics’ technology to develop encapsulated cell therapies for the treatment of type 1 diabetes. Under the terms, Sigilon will use its Afibromer platform to ‘encapsulate’ – the process of immobilising cells with a …
Lilly researches cell therapies for type 1 diabetes with Sigilonpharmaphorum
Lilly and Sigilon partner to develop diabetes type I therapiesPharmaTimes

all 3 news articles »

Continue reading

2018-04-05 Michael Zand NEWS

New trial to test stem cell-based retinal implant for dry age-related macular degeneration – News-Medical.net

News-Medical.netNew trial to test stem cell-based retinal implant for dry age-related macular degenerationNews-Medical.netPhysicians and researchers at the USC Roski Eye Institute have collaborated with other California institutions to show that a firs… Continue reading

2018-04-05 Michael Zand NEWS
  • 1
  • …
  • 296
  • 297
  • 298
  • 299
  • 300
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Gene Therapy Advances: What Health Execs Should Know
ModernMedicine
Although only three gene therapies have been approved in the United States—all in 2017—these innovative treatments are leaving their imprint on the healthcare system. Novartis’ Kymriah (tisagenlecleucel), a chimeric antigen receptor (CAR)T-cell …